1Department of Hygiene-Chemistry, Faculty of Pharmaceutical Sciences, Science University of Tokyo, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Papaverine and prostaglandin E2 (PGE2) synergistically induce neuroendocrine differentiation in prostate cancer cells. This novel therapy significantly reduces cancer cell proliferation and malignancy, offering a promising new avenue for prostate cancer treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: